Some of our trusted clients

Hustle Is Our Strategy

Ferox: Latin for courageous. Fierce. Aggressive. The root of ferocious — and the mindset we bring to every challenge.
At Ferox Strategies, our seasoned government and public affairs experts embody these values every day. We move fast, fight smart, and never back down.
The Ferox team balances force and focus, understanding each client’s unique goals, adapting strategies accordingly, and remaining relentlessly outcome-driven.

Client satisfaction isn’t a bonus – it’s the benchmark.

Explore Ferox Services

Better Services, Better Relations

We don’t wait for luck — we build it. Our team of experts and advocates designs bold, multi-pronged strategies, then executes with precision to deliver real results.

Ferox Strategies Services

View all of our services

Tax & Trade
Transportation & Infrastructure
Agriculture & Nutrition
Environment & Sustainability
Ferox Strategies

Policy Expertise

We’re more than a sounding board — we’re a step ahead. We know our clients so well that insight, advice, and strategy often come before the ask.

  • Agriculture & Nutrition

  • Artificial Intelligence

  • Border Security & Immigration

  • Budget & Appropriations

  • CFIUS

  • Congressional Investigations

  • Corporate Governance

  • Defense & Homeland Security

  • Education & Workforce Development

  • Environment & Sustainability

  • Healthcare & Life Sciences

  • Labor & Employment

  • Reputation Enhancement

  • Retail

  • Tax & Trade

  • Telecommunications & Technology

  • Transportation & Infrastructure

Follow Us On Social Media

Ferox adds four! We are thrilled to announce Remitly, Bel, Atrium Therapeutics, and Connect America's Aging in Place as new clients!

Remitly is an online remittance service that provides fast, secure, and transparent international money transfers to over 170 countries. 

Age in Place is a digital health company dedicated to elevating the well‑being and physical vitality of older adults so they may remain in their own homes and neighborhoods.

Atrium Therapeutics is a biopharmaceutical company developing RNA‑based therapies for cardiomyopathy and focuses on overcoming key limitations of viral and nanoparticle delivery.

Bel Brands USA is a major dairy, fruit, and plant-based snack company known for iconic brands like Babybel, The Laughing Cow, and Boursin. The company focuses on portion-controlled, convenient, and sustainable snacking. 

#FriendsofFerox #Welcome #NewClient #GovernmentAffairs
Seven consecutive years. Hustle will always be our strategy.

Ferox Strategies has been named a @bloomberg.government Top-Performing Lobbying Firm for seven years in a row, thanks to #TeamFerox and our #FriendsofFerox

Read the full report here: https://assets.bbhub.io/bna/sites/20/2025/04/2025-Top-Performing-Lobbying-Firms-Report.pdf

#TopLobbyist2025 #ItsWhatWeDo #Hustle #GovernmentRelations
Welcome back to #TheHustle, your primer on the latest Beltway news from the bipartisan team @feroxstrategies.

In the latest edition of The Hustle, we dive into all of the news you may have missed in the whirlwind of the first quarter and all that is to come! From tariffs to elections to funding lapses and even a new cabinet secretary, Ferox has you covered. 

Visit the link below for the full Hustle: https://mailchi.mp/feroxstrategies/ferox-strategies-presents-the-hustle-18046694?e=[UNIQID]

#Hustle #BeltwayNews #FriendsofFerox #Tariffs
Check out Health Policy Manager Zack Friend's article: "The Pharma Section 232 Proclamation is Here. What It Means and Who Gets a Pass."

The Trump Administration moved quickly after announcing its Section 232 pharmaceutical tariffs on April 2, 2026. After a year-long investigation into whether U.S. reliance on imported drugs poses a national security threat, the Commerce Department concluded that it does, and the President acted.

"Engaging now, before the guidance drops and before the July implementation deadline, is the only way to protect against outcomes that could have been avoided."

Check out the full article here: https://feroxstrategies.com/insight/the-pharma-section-232-proclamation-is-here/

#HealthPolicy #Pharma232 #PharmaTariffs
Check out Policy Analyst Andrew LoCicero's article entitled, "Golden Dome: Policy Analysis."

Since President Trump introduced the Golden Dome concept, there have been questions about how it would work, the cost, and its feasibility. Andrew's article explores this, as he dives into the Golden Dome's intended objective, function, cost, and practicality. With this, he tears back the layers of what other systems could be involved and the President's goals for the Golden Dome's capabilities. 

"The Golden Dome is a highly advanced and aspirational concept to defend the U.S. from a variety of adversary missile attacks. While systems exist to protect the country and smaller regional zones, the size and scope of the Golden Dome would be far above current capacity."

Check out the full article here: https://feroxstrategies.com/insight/golden-dome/

#DefensePolicy #MissileDefense #GoldenDome
Check out Manager of Government Affairs Lauren Doepke's article entitled, "What's In Your Water? The 2026 Federal Drinking Water Outlook Is Fluid." 

Between the Water Resources Development Act (WRDA) and PFAS battles being fought in DC Circuit Court, 2026 is shaping up to be a big year for water. Catch updates and an end-of-year outlook in Lauren's article. 

“Drinking water policy in 2026 is a study in simultaneous action and retreat... The real policy leverage this year lies at the intersection of WRDA negotiations, UCMR finalization, and the D.C. Circuit’s handling of PFAS litigation. Organizations that engage proactively with Congress, the EPA’s comment processes, and state-level regulators filling federal gaps will be far better positioned than those waiting for a unified federal signal that may not come.”

https://lnkd.in/ezrX7he5

#DrinkingWater #WRDA #PFAS #2026FederalOutlook